Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?
- PMID: 15643239
- DOI: 10.1097/01.ju.0000149870.36577.05
Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?
Abstract
Purpose: We evaluated the efficacy of testosterone gel (T-gel) alone and in combination with sildenafil in hypogonadal patients with erectile dysfunction (ED).
Materials and methods: A total of 49 hypogonadal men (mean age 60.7 years) with ED participated for a mean of 20.2 months. Blood was tested for total and bioavailable testosterone, and prostate specific antigen. Sexual function was assessed using the International Index of Erectile Function questionnaire and a global assessment question (GAQ). Men received 1% 5 gm T-gel for 6 months, and 100 mg sildenafil was added to those with a "no" response to the GAQ after 3 months on testosterone supplement.
Results: A total of 31 patients reported significant improvement in the sexual desire domain (from a mean +/- SD of 4.2 +/- 0.8 to 8.6 +/- 0.4) and erectile function (EF) domain (from 13.6 +/- 1.9 to 27 +/- 0.8) following treatment with testosterone supplement alone. One patient was excluded from study after urinary retention developed and 9 reported irritation at the gel application site. In spite of normalization of total and bioavailable testosterone values, and significant improvement of sexual desire domain scores, the EF of 17 men remained less than 26 or they responded "no" to the GAQ. These men received combined T-gel and sildenafil, after which all graded EF greater than 26 and responded positively to the GAQ.
Conclusions: Combined treatment with sildenafil and T-gel has a beneficial effect on ED in hypogonadal patients in whom treatment with testosterone supplement alone failed.
Comment in
-
Erectile function: the barometer of men's health.J Urol. 2005 Feb;173(2):341. doi: 10.1097/01.ju.0000151625.04932.07. J Urol. 2005. PMID: 15643171 No abstract available.
Similar articles
-
Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.J Urol. 2004 Aug;172(2):658-63. doi: 10.1097/01.ju.0000132389.97804.d7. J Urol. 2004. PMID: 15247755 Clinical Trial.
-
Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.Int J Impot Res. 2006 Jul-Aug;18(4):400-4. doi: 10.1038/sj.ijir.3901446. Epub 2006 Jan 5. Int J Impot Res. 2006. PMID: 16395321 Clinical Trial.
-
Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone.Urology. 2006 Mar;67(3):571-4. doi: 10.1016/j.urology.2005.09.032. Urology. 2006. PMID: 16527581 Clinical Trial.
-
Testosterone therapy in erectile dysfunction and hypogonadism.J Sex Med. 2005 Nov;2(6):785-92. doi: 10.1111/j.1743-6109.2005.00139.x. J Sex Med. 2005. PMID: 16422803 Review.
-
Erectile dysfunction in aging men: testosterone role in therapeutic protocols.J Endocrinol Invest. 2005;28(11 Suppl Proceedings):108-11. J Endocrinol Invest. 2005. PMID: 16760637 Review.
Cited by
-
Andropause: Current concepts.Indian J Endocrinol Metab. 2013 Dec;17(Suppl 3):S621-9. doi: 10.4103/2230-8210.123552. Indian J Endocrinol Metab. 2013. PMID: 24910824 Free PMC article. Review.
-
Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.Curr Urol Rep. 2005 Nov;6(6):476-81. doi: 10.1007/s11934-005-0044-z. Curr Urol Rep. 2005. PMID: 16238923 Review.
-
Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence.Clin Interv Aging. 2006;1(4):403-14. doi: 10.2147/ciia.2006.1.4.403. Clin Interv Aging. 2006. PMID: 18046917 Free PMC article. Review.
-
Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications.Front Endocrinol (Lausanne). 2019 Apr 11;10:225. doi: 10.3389/fendo.2019.00225. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31110491 Free PMC article. Review.
-
Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review.Can Urol Assoc J. 2012 Aug;6(4):269-74. doi: 10.5489/cuaj.11291. Can Urol Assoc J. 2012. PMID: 23093538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical